What happened with the injectable form of nitric oxide being the key delivery method of R-107? Salzman stated that the inhaled version isn't practical or as an effective way of delivering NO. Perhaps cost effectiveness is what they're aiming for with their inhaler. However, this might also signal a strategic collaboration and are in the process of entering into similar agreements with other companies as stated in the March 3 news release.
Development of R-107 Nasal Spray Designed to Provide Sustained Release of Nitric Oxide in the Nasal Cavities